Hashimoto's thyroiditis in patients with normal thyroid-stimulating hormone levels

Expert Review of Endocrinology and Metabolism

Volumn 7, Issue 2, 2012, Pages 175-179

  Promberger, Regina ^a,b   Hermann, Michael ^a   Ott, Johannes ^a,b  

^a Kaiserin Elisabeth Spital ^*  (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

autoimmune thyroiditis; autoimmunity; complications; euthyroidism; general health; Hashimoto's thyroiditis; quality of life; therapy

Indexed keywords

LEVOTHYROXINE; PRASTERONE; SELENIUM; THYROTROPIN;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; FIBROMYALGIA; HASHIMOTO DISEASE; HEART LEFT VENTRICLE PERFORMANCE; HUMAN; MENTAL DISEASE; NEUROPSYCHOLOGY; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; THYROID CANCER; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL;

EID: 84858111012     PISSN: 17446651     EISSN: 17448417     Source Type: Journal    
DOI: 10.1586/eem.12.3     Document Type: Article

References (56)

1. Hayashi N, Tamaki N, Konishi J et al. Sonography of Hashimoto's thyroiditis. J. Clin. Ultrasound 14, 123-126 (1986).
2. Jenkins RC, Weetman AP. Disease associations with autoimmune thyroid disease. Thyroid 12, 977-988 (2002).
3. Bianchi GP, Zaccheroni V, Solaroli E et al. Health-related quality of life in patients with thyroid disorders. Qual. Life Res. 13, 45-54 (2004).
4. Ott J, Promberger R, Kober F et al. Hashimoto's thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective case-control study in women undergoing thyroidectomy for benign goiter. Thyroid 21, 161-167 (2011).
5. Dickson A, Toft A, O'Carroll RE. Neuropsychological functioning, illness perception, mood and quality of life in chronic fatigue syndrome, autoimmune thyroid disease and healthy participants. Psychol. Med. 39, 1567-1576 (2009).
6. Boelaert K, Newby PR, Simmonds MJ et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am. J. Med. 123, e1831-e1839 (2010).
7. Franchini M, Lippi G, Manzato F et al. Thyroid-associated autoimmune coagulation disorders. J. Thromb. Thrombolysis 29, 87-91 (2010).
8. Bozec A, Lassalle S, Hofman V et al. The thyroid gland: a crossroad in inflammation-induced carcinoma? An ongoing debate with new therapeutic potential. Curr. Med. Chem. 17, 3449-3461 (2010).
9. Nikiforov YE. RET/PTC rearrangement - a link between Hashimoto's thyroiditis and thyroid cancer.or not. J. Clin. Endocrinol. Metab. 91(6), 2040-2042 (2006).
10. Pacini F, Vorontsova T, Demidchik EP et al. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J. Clin. Endocrinol. Metab. 82(11), 3563-3569 (1997).
11. Ott J, Meusel M, Schultheis A et al. The incidence of lymphocytic thyroid infiltration and Hashimoto's thyroiditis increased in patients operated for benign goiter over a 31-year period. Virchows Arch. 459, 277-281 (2011).
12. Mukasa K, Noh JY, Kunii Y et al. Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases. Thyroid 21, 37-41 (2011).
13. Pradeep PV, Ragavan M, Ramakrishna BA et al. Surgery in Hashimoto's thyroiditis: indications, complications, and associated cancers. J. Postgrad. Med. 57, 120-122 (2011).
14. Ganie MA, Marwaha RK, Aggarwal R et al. High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case-control study. Eur. J. Endocrinol. 162, 1117-1122 (2010).
15. Gleicher N, Barad D, Weghofer A. Functional autoantibodies, a new paradigm in autoimmunity? Autoimmun. Rev. 7, 42-45 (2007).
16. Ott J, Aust S, Kurz C et al. Elevated antithyroid peroxidase antibodies indicating Hashimoto's thyroiditis are associated with the treatment response in infertile women with polycystic ovary syndrome. Fertil. Steril. 94, 2895-2897 (2010).
17. Matalon ST, Blank M, Ornoy A et al. The association between anti-thyroid antibodies and pregnancy loss. Am. J. Reprod. Immunol. 45, 72-77 (2001).
18. Muller AF, Berghout A. Consequences of autoimmune thyroiditis before, during and after pregnancy. Minerva Endocrinol. 28, 247-254 (2003).
19. Rovelli R, Vigone MC, Giovanettoni C et al. Newborn of mothers affected by autoimmune thyroiditis: the importance of thyroid function monitoring in the first months of life. Ital. J. Pediatr. 36, 24-28 (2010).
20. Mocellin R, Walterfang M, Velakoulis D. Hashimoto's encephalopathy: epidemiology, pathogenesis and management. CNS Drugs 21, 799-811 (2007).
21. Tamagno G, Federspil G, Murialdo G. Clinical and diagnostic aspects of encephalopathy associated with autoimmune thyroid disease (or Hashimoto's encephalopathy). Intern. Emerg. Med. 1, 15-23 (2006).
22. Schiess N, Pardo CA. Hashimoto's encephalopathy. Ann. NY Acad. Sci. 1142, 254-265 (2008).
23. Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy syndrome or myth? Arch. Neurol. 60, 164-171 (2003).
24. Watemberg N, Greenstein D, Levine A. Encephalopathy associated with Hashimoto thyroiditis: pediatric perspective. J. Child Neurol. 21, 1-5 (2006).
25. Aydin-Ozemir Z, Tüzün E, Baykan B et al. Autoimmune thyroid encephalopathy presenting with epilepsia partialis continua. Clin. EEG Neurosc. 37, 204-209 (2006).
26. Maydell B, Kopp M, Komorowski GV et al. Hashimoto encephalopathy-is it underdiagnosed in pediatric patients? Neuropediatrics 33, 86-89 (2002).
27. Marshall GA, Doyle JJ. Long-term treatment of Hashimoto's encephalopathy. J. Neuropsychiatry Clin. Neurosci. 18, 14-20 (2006).
28. Vasconcellos E, Pina-Garza JE, Fakhoury T, Fenichel GM. Pediatric manifestations of Hashimoto's encephalopathy. Pediatr. Neurol. 20, 394-398 (1999).
29. Müssig K, Leyhe T, Holzmüller S et al. Increased prevalence of antibodies to central nervous system tissue and gangliosides in Hashimoto's thyroiditis compared to other thyroid illnesses. Psychoneuroendocrinology 34, 1252-1256 (2009).
30. Papi G, Guidetti G, Corsello SM et al. The association between benign paroxysmal positional vertigo and autoimmune chronic thyroiditis is not related to thyroid status. Thyroid 20, 237-238 (2010).
31. Akgul E, Kutuk U, Ertek S et al. Cardiac autonomic function and global left ventricular performance in autoimmune eauthyroid chronic thyroiditis: is treatment necessary at the euthyroid stage? Echocardiography 28, 15-21 (2011).
32. Evangelopoulou ME, Alevizaki M, Toumanidis S et al. Mitral valve prolapse in autoimmune thyroid disease: an index of systemic autoimmunity? Thyroid 9, 973-977 (1999).
33. Evangelopoulos ME, Toumanidis S, Sotou D et al. Mitral valve prolapse in young healthy individuals. An early index of autoimmunity? Lupus 18, 436-540 (2009).
34. Saliba W, El Fakih R, Shaheen W. Heart failure secondary to selenium deficiency, reversible after supplementation. Int. J. Cardiol. 28, 141(2), e26-e27 ( 2010).
35. Ebert EC. The thyroid and the gut. J. Clin. Gastroenterol. 44, 402-406 (2010).
36. Bazzichi L, Rossi A, Zirafa C et al. Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia? Rheumatol. Int. 32, 335-341 (2012).
37. Benvenga S, Trimarchi F. Changed presentation of Hashimoto's thyroiditis in North-Eastern Sicily and Calabria (Southern Italy) based on a 31-year experience. Thyroid 18, 429-441 (2008).
38. Rizzo M, Rossi RT, Bonaffini O et al. Increased annual frequency of Hashimoto's thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. Ann. Endocrinol. (Paris) 71, 525-534 (2010).
39. Carayanniotis G. Molecular parameters linking thyroglobulin iodination with autoimmune thyroiditis. Hormones (Athens) 10, 27-35 (2011).
40. McManus C, Luo J, Sippel R et al. Should patients with symptomatic Hashimoto's thyroiditis pursue surgery? J. Surg. Res. 170, 52-55 (2011).
41. Tektonidou MG, Margarita A, Vlachoyiannopoulos P et al. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann. Rheum. Dis. 63, 1159-1161 (2004).
42. Biró E, Szekanecz Z, Czirják L et al. Association of systemic and thyroid autoimmnune diseases. Clin. Rheumatol. 25, 240-245 (2006).
43. Gärtner R, Gasnier BC, Dietrich JW et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J. Clin. Endocrinol. Metab. 87, 1687-1691 (2002).
44. Gärtner R, Gasnier BC. Selenium in the treatment of autoimmune thyroiditis. Biofactors 19, 65-170 (2003).
45. Karanikas G, Schuetz M, Kontur S et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid 18, 7-12 (2008).
46. Toulis KA, Anastasilakis AD, Tzellos TG, Goulis DG, Kouvelas D. Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis. Thyroid 20, 1163-1173 (2010).
47. Köhrle J, Gärtner R. Selenium and thyroid. Best Pract. Res. Clin. Endocrinol. Metab. 23, 815-827 (2009).
48. Padberg S, Heller K, Usadel KH et al. One-year prophylactic treatment of euthyroid Hashimoto's thyroiditis patients with levothyroxine: is there a benefit? Thyroid 11, 249-255 (2001).
49. Aksoy DY, Kerimoglu U, Okur H et al. Effects of prophylactic thyroid hormone replacement in euthyroid Hashimoto's thyroiditis. Endocr. J. 52, 337-343 (2005).
50. Konno N, Yuri K, Taguchi H et al. Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodide determinations. Clin. Endocrinol. 38, 273-281 (1993).
51. Eising EG, Jentzen W, Freudenberg L et al. Value of low levels of anti-TPO antibodies in patients with suspicion of hashimoto thyroiditis. Endocrinologist 17, 83-84 (2007).
52. Solerte SB, Precerutti S, Gazzaruso C et al. Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate. Eur. J. Endocrinol. 152, 703-712 (2005).
53. Crosbie D, Black C, McIntyre L et al. Dehydroepiandrosterone for systemic lupus erythematosus. Cochrane Database Syst. Rev. 4, CD005114 (2007).
54. Röntzsch A, Thoss K, Petrow PK, Henzgen S, Bräuer R. Amelioration of murine antigen-induced arthritis by dehydroepiandrosterone (DHEA). Inflamm. Res. 53, 189-198 (2004).
55. Gleicher N, Ryan E, Weghofer A et al. Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study. Reprod. Biol. Endocrinol. 7, 108-114 (2009).
56. López-Marure R, Contreras PG, Dillon JS. Effects of dehydroepiandrosterone on proliferation, migration, and death of breast cancer cells. Eur. J. Pharmacol. 660, 268-274 (2011).